Genedata Announces Licensing Agreement with Gilead Sciences to Enhance Data Science Innovation in Discovery Research

Platform strengthens Gilead’s Research’s data science capabilities to accelerate research pipeline of transformative therapies Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a licensing agreement with Gilead Sciences, Inc. to help the company leverage the power of multi-omics data in the discovery of life-changing therapeutics across multiple [...]

KromaTiD Launches directional Genomic Hybridization (dGH) in-Site™ DNA Probes, Expanding Access for Cell and Gene Therapy Research Programs

LONGMONT, Colo. - KromaTiD, a single-cell analysis life science tools company focused on the research, development and commercialization of products for the cell and gene therapy market, announced today the launch of over 300 centromere, telomere and gene probes for use in directional Genomic Hybridization (dGH) in-Site™ assays. KromaTiD dGH™ products and services are widely used [...]

Elemental Machines Announces Edward Seguine As New Chief Executive Officer

Leadership Transition Signals Deeper Commitment To Life Sciences Market CAMBRIDGE, Mass. – Elemental Machines (EM), the pioneering developer of the comprehensive Intelligent Operations Platform for life sciences, has appointed Ed Seguine as Chief Executive Officer. Sridhar Iyengar, PhD, founder and incumbent CEO, will remain actively involved day-to-day as Chief Innovation Officer, leading the development of new [...]

Celtarys extends its chemical conjugation technology to the development of new fluorescent ligands for E3 Ubiquitin ligases

Traditional pharmacological mechanisms leave a significant part of the genome ‘undruggable’, due to the inability to induce or block their activity using agonists and antagonists. Thanks to the discovery of molecules capable of hijacking de ubiquitin-proteosome system like PROTACs (PROteolysis TArgetting Chimeras), the current druggable genome has expanded and this is now one of the hottest topics [...]

Xenocs Announces a New Partner in the Middle East

Grenoble -- Xenocs is delighted to announce a new partnership with ProLab Systems, a leading laboratory solution provider in the Middle East. This company will represent Xenocs in this region. This partnership marks a significant expansion into the Middle East region and represents Xenocs’ deep commitment to serving the diverse and vibrant markets in this [...]

Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates

Creative Diagnostics has announced a series of new reagent solutions to assist researchers in the bioanalysis of ADCs. NEW YORK, UNITED STATES-- Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced a series of new reagent solutions to assist researchers in the bioanalysis of antibody-drug conjugates (ADCs), including ELISA kits, anti-drug antibodies, [...]

FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis

MINNEAPOLIS, FOXO Technologies Inc.™ (NYSEAM: FOXO), a leader in the field of commercializing epigenetic biomarker technology, today announced the launch of its cutting-edge Bioinformatics Services to accelerate breakthroughs in biology, biotechnology, and healthcare, and redefine the growing field of epigenetic research. FOXO’s Bioinformatics Services offers a comprehensive platform of advanced data solutions tailored to meet the [...]

PromoCell Launches PromoExQ MSC Growth Medium XF for GMP Compliant Long-term Expansion of Mesenchymal Stem Cells

Heidelberg, Germany – PromoCell, a leading manufacturer of cell culture products, announced the launch of PromoExQ MSC Growth Medium XF, a serum- and xeno-free cell culture medium designed for GMP compliant maintenance and long-term expansion of mesenchymal stem cells (MSCs) for cell therapy manufacturing applications.PromoExQ MSC Growth Medium XF enables the long-term expansion of a [...]

Exploring Neurodegenerative Diseases in Microgravity

AMSBIO, a leading supplier of human cell lines and research tools, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM). The students undertook an exciting project aimed at advancing our understanding of neurodegenerative disorders, particularly Alzheimer’s disease, through spaceborne experiments. The aim of the ADDONISS (Ageing and [...]

UNION PARK CAPITAL SELLS PROCESS INSIGHTS TO INDUSTRIAL GROWTH PARTNERS

Boston, MA –  Union Park Capital (“UPC”) is pleased to announce the sale of Process Insights Inc. (“Process Insights” or the “Company”) to Industrial Growth Partners (“IGP”).  The acquisition of Process Insights marks an exciting milestone for both companies and underscores Union Park Capital's commitment to delivering exceptional value to its investors and portfolio companies. [...]

Access IBO on Knowledge Center